Noladin ether, a putative endocannabinoid, inhibits mu-opioid receptor activation via CB2 cannabinoid receptors.
| Image |  |
|---|---|
| Description | scientific article published on 04 July 2007 |
| Author/s |
author: Erika Bereczki Sandor Benyhe |
| Publication date | July 4, 2007 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |